PESAA13	Soluble interferon receptor (sIFNAR2) inhibits HIV-1 infection in macrophages through IFN-Î²-independent pathways	Poster exhibition	Innate immunity (including NK cells)
EPF138	New opportunities in engagement: the expansion of Civil Society advisory groups by product developers	E-poster	Inclusion considerations for research and development and other trials
EPLBF07	Advancing HIV prevention research in pregnant and breastfeeding populations (PBFP): priority advocacy objectives and next steps	E-poster	Inclusion considerations for research and development and other trials
EPE002	Implementation strategy package improves PrEP implementation for pregnant women in antenatal care clinics in western Kenya	E-poster	Implementation science of scaling up prevention (including PrEP)
EPE004	Introducing a comprehensive approach to implementing, scaling up, and strengthening HIV pre-exposure prophylaxis (PrEP) service delivery in Ukraine	E-poster	Implementation science of scaling up prevention (including PrEP)
EPE005	PrEP awareness and factors associated with PrEP interest among adults in Malawi: results from the MPHIA 2020	E-poster	Implementation science of scaling up prevention (including PrEP)
EPE006	High demand for HIV pre-exposure prophylaxis (PrEP) services amongst key populations in Sierra Leone: early lessons from the country's first PrEP program	E-poster	Implementation science of scaling up prevention (including PrEP)
EPE007	Delivery of HIV self-testing and pre-exposure prophylaxis through private retail pharmacies in Kenya: a mixed methods evaluation	E-poster	Implementation science of scaling up prevention (including PrEP)
EPE008	'PrEP Discussion Paradox' at primary care settings: perspectives regarding PrEP care from patients and healthcare providers	E-poster	Implementation science of scaling up prevention (including PrEP)
EPE009	Gamification of peer mobilizers to increase pre-exposure prophylaxis uptake among transgender women	E-poster	Implementation science of scaling up prevention (including PrEP)